6De Champs C, Sirot D, Chanal C, Bonnet R, Sirot J. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. The French Study Group. Antimicrobial Agents and Chemotherapy, 2000, 44(11): 3177-3179.
7Chouchani C, Berlemont R, Masmoudi A, Galleni M, Frere J M, Belhadj O, Ben-Mahrez K. A novel extended-spectrum TEM-type β-lactamase, TEM-138, from Salmonella enterica serovar infantis. Antimicrobial Agents and Chemotherapy, 2006, 50(9): 3183-3185.
8Lewis J S 2nd, Hen'era M, Wickes B, Patterson J E, Jorgensen J H. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U. S. health care system. Antimicrobial Agents and Chemotherapy, 2007, 51(11): 4015-4021.
9Kim J, Lim Y M, Jeong Y S, Seol S Y, Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrobial Agents and Chemotherapy, 2005, 49(4): 1572-1575.
10Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, Philippon A, Arlet G. Dissemination of CTX-M-Type β-Lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrobial Agents and Chemotherapy, 2004, 48(4): 1249-1255.
